# Cero Therapeutics Holdings, Inc.: Form 8-K, filed May 29, 2026

- Company: [Cero Therapeutics Holdings, Inc.](/companies/cero.md) (CIK 1870404)
- Form: 8-K
- Filed: 2026-05-29
- Accepted by EDGAR: May 29, 2026, 20:05 ET
- Period: 2026-05-28
- Accession: 0001213900-26-062802
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1870404/000121390026062802/ea0292715-8k_cero.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1870404/000121390026062802/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1870404/000121390026062802/ea0292715-8k_cero.htm

Filed May 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-062802. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.